Alessandra Boletta Selected Research

Alessandra Boletta Research Topics

Disease

18	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2022 - 01/2006
11	Polycystic Kidney Diseases (Polycystic Kidney Disease) 04/2024 - 10/2009
9	Cysts 01/2020 - 01/2006
3	Neoplasms (Cancer) 01/2022 - 11/2020
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2020 - 01/2018
2	Disease Progression 11/2019 - 08/2017
2	Cystic Kidney Diseases (Cystic Kidney Disease) 04/2016 - 12/2012
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Lymphoma (Lymphomas) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Erdheim-Chester Disease 10/2021
1	Infections 01/2021
1	Inflammation (Inflammations) 01/2021
1	Neoplasm Metastasis (Metastasis) 11/2020
1	Body Weight (Weight, Body) 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Kidney Neoplasms (Kidney Cancer) 01/2019
1	Papillary Carcinoma 01/2019
1	Cystadenoma 01/2019
1	Carcinogenesis 01/2018
1	Ischemia 04/2016
1	Tuberous Sclerosis (Bourneville's Disease) 03/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2016
1	Hydrocephalus (Hydrocephaly) 08/2015
1	Retinal Degeneration 11/2014
1	Ciliopathies 11/2014
1	Hypertension (High Blood Pressure) 07/2010
1	Vascular Remodeling 07/2010
1	Fibrosis (Cirrhosis) 07/2010
1	Wounds and Injuries (Trauma) 10/2007

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2006
5	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 04/2013
3	EnzymesIBA 01/2022 - 04/2016
3	Mechanistic Target of Rapamycin Complex 1IBA 01/2020 - 01/2018
3	Sirolimus (Rapamycin)FDA Link 04/2017 - 10/2009
2	IACS-010759IBA 01/2023 - 01/2022
2	CytokinesIBA 10/2021 - 01/2021
2	ActomyosinIBA 01/2021 - 11/2019
2	FumaratesIBA 01/2019 - 01/2018
2	polycystic kidney disease 1 proteinIBA 11/2018 - 04/2016
2	Deoxyglucose (2 Deoxy D glucose)IBA 08/2017 - 01/2016
2	Phosphotransferases (Kinase)IBA 04/2017 - 10/2009
2	beta CateninIBA 12/2012 - 10/2007
1	Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA 04/2024
1	S63845IBA 01/2022
1	venetoclaxIBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	Histones (Histone)IBA 01/2021
1	AntibodiesIBA 01/2021
1	VaccinesIBA 01/2021
1	3- (2,4- dichloro- 5- methoxyphenyl)- 2- sulfanyl- 4(3H)- quinazolinoneIBA 01/2020
1	fasudil (AT 877)IBA 11/2019
1	Tricarboxylic AcidsIBA 01/2019
1	Fumarate Hydratase (Fumarase)IBA 01/2019
1	TRPP Cation ChannelsIBA 11/2018
1	Casein Kinases (Casein Kinase)IBA 01/2018
1	RoscovitineIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2018
1	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 04/2017
1	Ion Channels (Ion Channel)IBA 01/2017
1	Phosphatidylinositols (Phosphatidylinositol)IBA 04/2016
1	trans-sodium crocetinate (crocetin)IBA 03/2016
1	Retinaldehyde (Retinal)IBA 11/2014
1	Rhodopsin (Visual Purple)IBA 11/2014
1	Mechanistic Target of Rapamycin Complex 2IBA 07/2010
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2010
1	MTOR InhibitorsIBA 07/2010
1	TOR Serine-Threonine KinasesIBA 10/2009
1	Cadherins (E-Cadherin)IBA 10/2007
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2006

Therapy/Procedure

8	Therapeutics 01/2022 - 04/2013